OPCH Insider Trading

Insider Ownership Percentage: 0.64%
Insider Buying (Last 12 Months): $969,220.00
Insider Selling (Last 12 Months): $3,227,231.90

Option Care Health Insider Trading History Chart

This chart shows the insider buying and selling history at Option Care Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$1.03MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M$0$200MTotal Insider BuyingTotal Insider Selling

Option Care Health Share Price & Price History

Current Price: $34.73
Price Change: Price Decrease of -0.47 (-1.34%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for OPCH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$34.73Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for Option Care Health (NASDAQ:OPCH)

98.05% of Option Care Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OPCH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$782Mbought$621MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500M$0$500MTotal InflowsTotal Outflows
Option Care Health logo
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Read More on Option Care Health

Today's Range

Now: $34.73
Low: $34.67
High: $35.23

50 Day Range

MA: $32.47
Low: $29.16
High: $35.20

52 Week Range

Now: $34.73
Low: $21.39
High: $35.53

Volume

1,378,809 shs

Average Volume

1,713,822 shs

Market Capitalization

$5.70 billion

P/E Ratio

29.18

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Option Care Health?

Option Care Health's top insider investors include:
  1. Harry M Jansen Kraemer Jr (Director)
  2. Michael H Shapiro (CFO)
  3. R Carter Pate (Director)
  4. Michael Bavaro (Insider)
  5. Elizabeth Quadros Betten (Director)
  6. Elizabeth D Bierbower (Director)
  7. Collin Smyser (Insider)
Learn More about top insider investors at Option Care Health.

Who are the major institutional investors of Option Care Health?

Option Care Health's top institutional shareholders include:
  1. Vanguard Group Inc. — 11.35%
  2. Wellington Management Group LLP — 11.08%
  3. FMR LLC — 2.87%
  4. Geode Capital Management LLC — 2.45%
  5. Dimensional Fund Advisors LP — 2.34%
  6. Fuller & Thaler Asset Management Inc. — 1.89%
Learn More about top institutional investors of Option Care Health stock.

Which institutional investors are selling Option Care Health stock?

Within the last quarter, OPCH stock was sold by these institutional investors:
  1. Thrivent Financial for Lutherans
  2. FMR LLC
  3. Bank of America Corp DE
  4. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  5. Invesco Ltd.
  6. Fuller & Thaler Asset Management Inc.
  7. Price T Rowe Associates Inc. MD
  8. Franklin Resources Inc.
Within the last year, company insiders that have sold Option Care Health company stock include:
  1. Harry M Jansen Kraemer Jr (Director)
  2. Michael H Shapiro (CFO)
  3. R Carter Pate (Director)
Learn More investors selling Option Care Health stock.

Which institutional investors are buying Option Care Health stock?

Within the last quarter, OPCH stock was acquired by institutional investors including:
  1. Wellington Management Group LLP
  2. Norges Bank
  3. Voloridge Investment Management LLC
  4. Freestone Grove Partners LP
  5. Dimensional Fund Advisors LP
  6. Victory Capital Management Inc.
  7. Alyeska Investment Group L.P.
  8. Magnetar Financial LLC
Within the last year, these company insiders have bought Option Care Health stock:
  1. Harry M Jansen Kraemer Jr (Director)
  2. Michael H Shapiro (CFO)
  3. R Carter Pate (Director)
  4. Michael Bavaro (Insider)
Learn More investors buying Option Care Health stock.